Pirtobrutinib is a BTK inhibitor, not the usual kind that sticks to the protein. It’s made to treat mantle cell lymphoma and CLL. It works by going after the BTK signaling pathway.
You’ve got two doses in tablet form: 50 mg and 100 mg. You’re supposed to take 200 mg a day, just one time. The medication comes in bottles containing 60 tablets each, with the active ingredient being pirtobrutinib.
This therapy is all about keeping that BTK activity under control, which is really important for dealing with these lymphoproliferative diseases.
